/
ASCO Meeting Library.js
153 lines (143 loc) · 15.4 KB
/
ASCO Meeting Library.js
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
{
"translatorID": "03d1aac2-bee2-43f4-8d9c-b96ef31e8c61",
"label": "ASCO Meeting Library",
"creator": "Sebastian Karcher",
"target": "^https?://meetinglibrary\\.asco\\.org/(content|search)",
"minVersion": "3.0",
"maxVersion": "",
"priority": 100,
"inRepository": true,
"translatorType": 4,
"browserSupport": "gcsibv",
"lastUpdated": "2021-06-07 16:47:39"
}
/* FW LINE 59:b820c6d */ function flatten(t){var e=new Array;for(var i in t){var r=t[i];r instanceof Array?e=e.concat(flatten(r)):e.push(r)}return e}var FW={_scrapers:new Array};FW._Base=function(){this.callHook=function(t,e,i,r){if("object"==typeof this.hooks){var n=this.hooks[t];"function"==typeof n&&n(e,i,r)}},this.evaluateThing=function(t,e,i){var r=typeof t;if("object"===r){if(t instanceof Array){var n=this.evaluateThing,a=t.map(function(t){return n(t,e,i)});return flatten(a)}return t.evaluate(e,i)}return"function"===r?t(e,i):t},this.makeItems=function(t,e,i,r,n){n()}},FW.Scraper=function(t){FW._scrapers.push(new FW._Scraper(t))},FW._Scraper=function(t){for(x in t)this[x]=t[x];this._singleFieldNames=["abstractNote","applicationNumber","archive","archiveLocation","artworkMedium","artworkSize","assignee","audioFileType","audioRecordingType","billNumber","blogTitle","bookTitle","callNumber","caseName","code","codeNumber","codePages","codeVolume","committee","company","conferenceName","country","court","date","dateDecided","dateEnacted","dictionaryTitle","distributor","docketNumber","documentNumber","DOI","edition","encyclopediaTitle","episodeNumber","extra","filingDate","firstPage","forumTitle","genre","history","institution","interviewMedium","ISBN","ISSN","issue","issueDate","issuingAuthority","journalAbbreviation","label","language","legalStatus","legislativeBody","letterType","libraryCatalog","manuscriptType","mapType","medium","meetingName","nameOfAct","network","number","numberOfVolumes","numPages","pages","patentNumber","place","postType","presentationType","priorityNumbers","proceedingsTitle","programTitle","programmingLanguage","publicLawNumber","publicationTitle","publisher","references","reportNumber","reportType","reporter","reporterVolume","rights","runningTime","scale","section","series","seriesNumber","seriesText","seriesTitle","session","shortTitle","studio","subject","system","thesisType","title","type","university","url","version","videoRecordingType","volume","websiteTitle","websiteType"],this._makeAttachments=function(t,e,i,r){if(i instanceof Array)i.forEach(function(i){this._makeAttachments(t,e,i,r)},this);else if("object"==typeof i){var n=i.urls||i.url,a=i.types||i.type,s=i.titles||i.title,o=i.snapshots||i.snapshot,u=this.evaluateThing(n,t,e),l=this.evaluateThing(s,t,e),c=this.evaluateThing(a,t,e),h=this.evaluateThing(o,t,e);u instanceof Array||(u=[u]);for(var f in u){var p,m,v,d=u[f];p=c instanceof Array?c[f]:c,m=l instanceof Array?l[f]:l,v=h instanceof Array?h[f]:h,r.attachments.push({url:d,title:m,mimeType:p,snapshot:v})}}},this.makeItems=function(t,e,i,r,n){var a=new Zotero.Item(this.itemType);a.url=e;for(var s in this._singleFieldNames){var o=this._singleFieldNames[s];if(this[o]){var u=this.evaluateThing(this[o],t,e);u instanceof Array?a[o]=u[0]:a[o]=u}}var l=["creators","tags"];for(var c in l){var h=l[c],f=this.evaluateThing(this[h],t,e);if(f)for(var p in f)a[h].push(f[p])}this._makeAttachments(t,e,this.attachments,a),r(a,this,t,e),n()}},FW._Scraper.prototype=new FW._Base,FW.MultiScraper=function(t){FW._scrapers.push(new FW._MultiScraper(t))},FW._MultiScraper=function(t){for(x in t)this[x]=t[x];this._mkSelectItems=function(t,e){var i=new Object;for(var r in t)i[e[r]]=t[r];return i},this._selectItems=function(t,e,i){var r=new Array;Zotero.selectItems(this._mkSelectItems(t,e),function(t){for(var e in t)r.push(e);i(r)})},this._mkAttachments=function(t,e,i){var r=this.evaluateThing(this.attachments,t,e),n=new Object;if(r)for(var a in i)n[i[a]]=r[a];return n},this._makeChoices=function(t,e,i,r,n){if(t instanceof Array)t.forEach(function(t){this._makeTitlesUrls(t,e,i,r,n)},this);else if("object"==typeof t){var a=t.urls||t.url,s=t.titles||t.title,o=this.evaluateThing(a,e,i),u=this.evaluateThing(s,e,i),l=u instanceof Array;o instanceof Array||(o=[o]);for(var c in o){var h,f=o[c];h=l?u[c]:u,n.push(f),r.push(h)}}},this.makeItems=function(t,e,i,r,n){if(this.beforeFilter){var a=this.beforeFilter(t,e);if(a!=e)return void this.makeItems(t,a,i,r,n)}var s=[],o=[];this._makeChoices(this.choices,t,e,s,o);var u=this._mkAttachments(t,e,o),l=this.itemTrans;this._selectItems(s,o,function(t){if(t){var e=function(t){var e=t.documentURI,i=l;void 0===i&&(i=FW.getScraper(t,e)),void 0===i||i.makeItems(t,e,u[e],r,function(){})};Zotero.Utilities.processDocuments(t,e,n)}else n()})}},FW._MultiScraper.prototype=new FW._Base,FW.WebDelegateTranslator=function(t){return new FW._WebDelegateTranslator(t)},FW._WebDelegateTranslator=function(t){for(x in t)this[x]=t[x];this.makeItems=function(t,e,i,r,n){var a=this,s=Zotero.loadTranslator("web");s.setHandler("itemDone",function(i,n){r(n,a,t,e)}),s.setDocument(t),this.translatorId?(s.setTranslator(this.translatorId),s.translate()):(s.setHandler("translators",function(t,e){e.length&&(s.setTranslator(e[0]),s.translate())}),s.getTranslators()),n()}},FW._WebDelegateTranslator.prototype=new FW._Base,FW._StringMagic=function(){this._filters=new Array,this.addFilter=function(t){return this._filters.push(t),this},this.split=function(t){return this.addFilter(function(e){return e.split(t).filter(function(t){return""!=t})})},this.replace=function(t,e,i){return this.addFilter(function(r){return r.match(t)?r.replace(t,e,i):r})},this.prepend=function(t){return this.replace(/^/,t)},this.append=function(t){return this.replace(/$/,t)},this.remove=function(t,e){return this.replace(t,"",e)},this.trim=function(){return this.addFilter(function(t){return Zotero.Utilities.trim(t)})},this.trimInternal=function(){return this.addFilter(function(t){return Zotero.Utilities.trimInternal(t)})},this.match=function(t,e){return e||(e=0),this.addFilter(function(i){var r=i.match(t);return void 0===r||null===r?void 0:r[e]})},this.cleanAuthor=function(t,e){return this.addFilter(function(i){return Zotero.Utilities.cleanAuthor(i,t,e)})},this.key=function(t){return this.addFilter(function(e){return e[t]})},this.capitalizeTitle=function(){return this.addFilter(function(t){return Zotero.Utilities.capitalizeTitle(t)})},this.unescapeHTML=function(){return this.addFilter(function(t){return Zotero.Utilities.unescapeHTML(t)})},this.unescape=function(){return this.addFilter(function(t){return unescape(t)})},this._applyFilters=function(t,e){for(i in this._filters){t=flatten(t),t=t.filter(function(t){return void 0!==t&&null!==t});for(var r=0;r<t.length;r++)try{if(void 0===t[r]||null===t[r])continue;t[r]=this._filters[i](t[r],e)}catch(n){t[r]=void 0,Zotero.debug("Caught exception "+n+"on filter: "+this._filters[i])}t=t.filter(function(t){return void 0!==t&&null!==t})}return flatten(t)}},FW.PageText=function(){return new FW._PageText},FW._PageText=function(){this._filters=new Array,this.evaluate=function(t){var e=[t.documentElement.innerHTML];return e=this._applyFilters(e,t),0==e.length?!1:e}},FW._PageText.prototype=new FW._StringMagic,FW.Url=function(){return new FW._Url},FW._Url=function(){this._filters=new Array,this.evaluate=function(t,e){var i=[e];return i=this._applyFilters(i,t),0==i.length?!1:i}},FW._Url.prototype=new FW._StringMagic,FW.Xpath=function(t){return new FW._Xpath(t)},FW._Xpath=function(t){this._xpath=t,this._filters=new Array,this.text=function(){var t=function(t){return"object"==typeof t&&t.textContent?t.textContent:t};return this.addFilter(t),this},this.sub=function(t){var e=function(e,i){var r=i.evaluate(t,e,null,XPathResult.ANY_TYPE,null);return r?r.iterateNext():void 0};return this.addFilter(e),this},this.evaluate=function(t){var e=t.evaluate(this._xpath,t,null,XPathResult.ANY_TYPE,null),i=e.resultType,r=new Array;if(i==XPathResult.STRING_TYPE)r.push(e.stringValue);else if(i==XPathResult.BOOLEAN_TYPE)r.push(e.booleanValue);else if(i==XPathResult.NUMBER_TYPE)r.push(e.numberValue);else if(i==XPathResult.ORDERED_NODE_ITERATOR_TYPE||i==XPathResult.UNORDERED_NODE_ITERATOR_TYPE)for(var n;n=e.iterateNext();)r.push(n);return r=this._applyFilters(r,t),0==r.length?!1:r}},FW._Xpath.prototype=new FW._StringMagic,FW.detectWeb=function(t,e){for(var i in FW._scrapers){var r=FW._scrapers[i],n=r.evaluateThing(r.itemType,t,e),a=r.evaluateThing(r.detect,t,e);if(a.length>0&&a[0])return n}},FW.getScraper=function(t,e){var i=FW.detectWeb(t,e);return FW._scrapers.filter(function(r){return r.evaluateThing(r.itemType,t,e)==i&&r.evaluateThing(r.detect,t,e)})[0]},FW.doWeb=function(t,e){var i=FW.getScraper(t,e);i.makeItems(t,e,[],function(t,e,i,r){e.callHook("scraperDone",t,i,r),t.title||(t.title=""),t.complete()},function(){Zotero.done()}),Zotero.wait()};
function detectWeb(doc, url) { return FW.detectWeb(doc, url); }
function doWeb(doc, url) { return FW.doWeb(doc, url); }
/*
***** BEGIN LICENSE BLOCK *****
Copyright © 2013 Sebastian Karcher
This file is part of Zotero.
Zotero is free software: you can redistribute it and/or modify
it under the terms of the GNU Affero General Public License as published by
the Free Software Foundation, either version 3 of the License, or
(at your option) any later version.
Zotero is distributed in the hope that it will be useful,
but WITHOUT ANY WARRANTY; without even the implied warranty of
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
GNU Affero General Public License for more details.
You should have received a copy of the GNU Affero General Public License
along with Zotero. If not, see <http://www.gnu.org/licenses/>.
***** END LICENSE BLOCK *****
*/
FW.Scraper({
itemType : 'journalArticle',
detect : FW.Url().match(/content\/\d+\-\d+/),
title : FW.Xpath ('//div[@class="content"]/h3').text().trim().replace(/\.$/, ''),
creators : FW.Xpath ('//div[contains(@class, "field-name-field-authors")]/div[@class="field-items"]')
.text().remove(/\;.*/m ).split(/\,/).replace(/\s/," ").cleanAuthor("author"),
date : FW.Xpath ('//div[contains(@class, "field-name-field-citation")]/div[@class="field-items"]').text().match( /\d{4}/ ).trim(),
publicationTitle : "Journal of Clinical Oncology",
journalAbbreviation: "J. Clin. Oncol.",
ISSN : "0732-183X",
url : FW.Url(),
volume: FW.Xpath ('//div[contains(@class, "field-name-field-citation")]/div[@class="field-items"]').text().remove(/,.+/).remove(/J Clin Oncol\s*/),
issue: FW.Xpath ('//div[contains(@class, "field-name-field-citation")]/div[@class="field-items"]').text().match(/\(.+\)/).remove(/[\(\)]/g),
abstractNote : FW.Xpath ('//div[@class="field-label" and contains(text(), "Abstract:")]/following-sibling::p').text().remove(/Background:/).trim(),
meetingName : FW.Xpath ('//div[contains(@class, "field-name-field-meeting")]/div[@class="field-items"]//a').text().trim(),
tags : FW.Xpath ('//div[contains(@class, "field-name-field-subcategories")]/div[@class="field-items"]//a').text().remove(/;[\s\S]*/).split(/\//).trim()
});
FW.MultiScraper({
itemType : 'multiple',
detect : FW.Url().match(/\/search\//),
choices : {
titles : FW.Xpath('//li[@class="search-result"]//h3[contains(@class, "title")]/a').text().trim(),
urls : FW.Xpath('//li[@class="search-result"]//h3[contains(@class, "title")]/a').key("href")
}
});/** BEGIN TEST CASES **/
var testCases = [
{
"type": "web",
"url": "http://meetinglibrary.asco.org/content/112732-132",
"items": [
{
"itemType": "journalArticle",
"title": "Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial",
"creators": [
{
"firstName": "Paul E.",
"lastName": "Goss",
"creatorType": "author"
},
{
"firstName": "Carlos H.",
"lastName": "Barrios",
"creatorType": "author"
},
{
"firstName": "Arlene",
"lastName": "Chan",
"creatorType": "author"
},
{
"firstName": "Dianne M.",
"lastName": "Finkelstein",
"creatorType": "author"
},
{
"firstName": "Hiroji",
"lastName": "Iwata",
"creatorType": "author"
},
{
"firstName": "Miguel",
"lastName": "Martin",
"creatorType": "author"
},
{
"firstName": "Ada",
"lastName": "Braun",
"creatorType": "author"
},
{
"firstName": "Beiying",
"lastName": "Ding",
"creatorType": "author"
},
{
"firstName": "Tapan",
"lastName": "Maniar",
"creatorType": "author"
},
{
"firstName": "Robert E.",
"lastName": "Coleman",
"creatorType": "author"
}
],
"date": "2013",
"ISSN": "0732-183X",
"abstractNote": "In women with early-stage breast cancer, bone is a common site of distant recurrence and represents approximately 40% of all first recurrences. Preclinical studies demonstrated that inhibition of RANKL significantly delays skeletal tumor formation, reduces skeletal tumor burden, and prolongs survival of tumor-bearing mice. Denosumab is approved for the prevention of skeletal-related events (SREs) in patients with established bone metastases from solid tumors. The D-CARE trial is designed to assess if denosumab treatment prolongs bone metastasis-free survival (BMFS) and disease-free survival (DFS) in the adjuvant breast cancer setting. The primary endpoint of this event-driven trial is BMFS. Secondary endpoints include DFS and overall survival. Additional endpoints include safety, breast density, time to first on-study SRE (following the development of bone metastasis), patient reported outcomes, and biomarkers. Methods: In this international, randomized, double-blind, and placebo-controlled phase 3 trial, 4509 women with stage II or III breast cancer at high risk for recurrence and with known hormone and HERE2 receptor status were randomized. High risk was defined as biopsy evidence of breast cancer in regional lymph nodes, tumor size > 5 cm (T3), or locally advanced disease (T4). Standard-of-care adjuvant or neoadjuvant chemo-, endocrine, or HER-2 targeted therapy, alone or in combination, must be planned. Patients with a prior history of breast cancer (except DCIS or LCIS) or distant metastasis, oral bisphosphonate (BP) use within 1 year of randomization, or any intravenous BP use, were not eligible. Patients were randomized 1:1 to receive denosumab 120 mg or placebo subcutaneously monthly for 6 months, then every 3 months for a total of 5 years of treatment. Supplemental vitamin D (≥ 400 IU) and calcium (≥ 500 mg) were required. The trial, sponsored by Amgen Inc., began enrolling patients in June 2010 and completed enrollment in late 2012. Clinical trial information: NCT01077154.",
"issue": "suppl; abstr TPS662",
"journalAbbreviation": "J. Clin. Oncol.",
"libraryCatalog": "ASCO Meeting Library",
"publicationTitle": "Journal of Clinical Oncology",
"shortTitle": "Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE)",
"url": "http://meetinglibrary.asco.org/content/112732-132",
"volume": "31",
"attachments": [],
"tags": [
"HER2+"
],
"notes": [],
"seeAlso": []
}
]
},
{
"type": "web",
"url": "http://meetinglibrary.asco.org/search/site/?f[0]=bundle_name%3AAbstract&f[1]=fctContentType%3AAbstract&the_title=test",
"items": "multiple"
}
]
/** END TEST CASES **/